report by BlackRock
Results for ""
Market Outlooks
Weekly Investment Commentary: Earnings seasoned with a grain of salt
This piece is approved to use with clients.
Inflation trends should benefit some areas more than others. So far, higher inflation has had a mixed impact on corporate earnings.
Market Outlooks
Weekly Investment Commentary: Don’t shrink from the Fed’s balance sheet runoff
This piece is approved to use with clients.
What a difference five years makes. Today’s backdrop for balance sheet reduction bears little resemblance to the last time the Fed initiated QT in September 2017.
Market Outlooks
Weekly Investment Commentary: Market turmoil shines a light on 60/40 conundrum
This piece is approved to use with clients.
History has not repeated. Comparing the 2022 market correction to history, the glaring difference is the performance of traditional fixed income.
Market Outlooks
Weekly Investment Commentary: In search of a motto for inflation nation
This piece is approved to use with clients.
Possibility, not inevitability. We continually debate different potential nearterm scenarios and their likelihood of occurring, and how various investments might perform.
Market Outlooks
Weekly Investment Commentary: Emerging markets: unfairly punished?
This piece is approved to use with clients.
Some EM equities might be cheap for a reason. With the MSCI EM Index trading nearly 20% below its 52-week high, it might appear on the surface to be a screaming value opportunity for investors with a tolerance for volatility.
Market Outlooks
FAQ: What Does Russia’s Invasion of Ukraine Mean for the Market?
This piece is approved to use with clients.
Mounting tensions between Russia and Ukraine resulted in a Russian invasion into Ukraine sovereign territory in February. We continue to monitor events and their impact on asset classes closely. As our conditions and our views evolve, we offer our perspective on the market’s response.
Market Outlooks
Weekly Investment Commentary: “Stagflation” may not mean what you think
This piece is approved to use with clients.
U.S. economic data supports still healthy (albeit modestly slower) growth.